Raw Retatrutide Peptide 30mg (R&D Only)

Raw Retatrutide Peptide 30mg is a high purity research grade peptide formulated for advanced scientific investigation. Retatrutide is a next generation triple receptor agonist that simultaneously activates the GIP, GLP-1 and glucagon receptors, making it one of the most studied compounds in contemporary metabolic and obesity research.

Each 30 mg vial of raw Retatrutide peptide is precision synthesized to deliver consistent molecular integrity, supporting reproducible and reliable laboratory outcomes. Researchers working in the fields of metabolic disease, adipose tissue biology and endocrine signaling rely on this compound for its potent multi-receptor activity and its well-documented pharmacological profile.

This raw peptide is supplied in lyophilized powder form, offering excellent stability during storage and extended shelf life when kept under proper laboratory conditions. The 30mg quantity is ideal for sustained research programs that require a consistent supply of Retatrutide peptide without frequent reordering.

The growing body of clinical and preclinical literature on Retatrutide positions it as a landmark compound in GIP GLP-1 glucagon receptor agonism, with studies highlighting its superior efficacy profile compared to earlier single or dual receptor agents. Raw Retatrutide 30mg gives your laboratory direct access to this cutting-edge peptide at research scale.

Key specifications:

• Purity: ≥98% by HPLC.
• Molecular form: lyophilized white powder.
• Storage: −20°C.
• CAS: 2381272-96-2.

WARNING: For research use only. Not intended for human or veterinary administration.